Q16548 (B2LA1_HUMAN) Homo sapiens (Human)
Bcl-2-related protein A1 UniProtKBInterProSTRINGInteractive Modelling
175 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
24 Experimental Structures
Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
---|---|---|---|---|---|---|
Human Bfl-1 in complex with a Bfl-1-specific selected peptide |
Heteromer | 100 | 2×SO4; | |||
Human Bfl-1 in complex with PUMA BH3 |
Heteromer Q9BXH1; | 100 | 1×SO4; | |||
Human Bfl-1 in complex with the Bfl-1-specific designed peptide srt.F4 |
Heteromer | 100 | 1×SO4; | |||
Human Bfl-1 in complex with the Bfl-1-specific designed peptide srt.F10 |
Heteromer | 100 | 1×SO4; | |||
Human Bfl-1 in complex with the designed peptide dF1 |
Heteromer | 100 | ||||
Human Bfl-1 covalently cross-linked to an electrophilic variant of a Bfl-1-specific selected peptide |
Heteromer | 100 | 2×SO4; | |||
Human Bfl-1 in complex with the designed peptide dF4 |
Heteromer | 100 | ||||
Crystal Structure of human BFL-1 in complex with NOXA BH3 peptide, Northeast Structural Genomics Co… |
Heteromer Q13794; | 100 | ||||
Crystal Structure of human BFL-1 in complex with tBid BH3 peptide, Northeast Structural Genomics Co… |
Heteromer P55957; | 100 | ||||
Human Bcl2-A1 in complex with Bim-BH3 peptide |
Heteromer O43521; | 100.0 | 1×SO4; | |||
Bfl-1 in complex with alpha helical peptide |
Heteromer O43521; | 100 | ||||
Crystal structure of human BFL-1 in complex with BAK BH3 peptide |
Heteromer Q16611; | 100.0 | ||||
Discovery of a Series of Covalent, Cell Active Bfl-1 Inhibitors | monomer | 100 | 1×A1IDO; | |||
BFL1 covalently bound to inhibitor compound 43 | monomer | 100.0 | 1×A1ILW; | |||
Discovery of a Series of Covalent, Cell Active Bfl-1 Inhibitors | monomer | 100 | 1×A1IDG; | |||
BFL1 covalently bound to inhibitor compound 13 | monomer | 100 | 1×BUD; 1×A1ILV; | |||
BFL1 covalently bound to inhibitor compound 7 | monomer | 100 | 1×A1ILY; | |||
Crystal Structure of Bcl-2-related protein A1 | monomer | 98.63 | 1×CAD; | |||
BFL1 covalently bound to inhibitor compound 39 | monomer | 100 | 1×A1ILX; | |||
BFL1 covalently bound to inhibitor compound 17 | monomer | 100.0 | 1×A1ILU; | |||
Discovery of a Series of Covalent, Cell Active Bfl-1 Inhibitors | monomer | 100 | 1×A1IDP; | |||
Crystal Structure Analysis of BFL1 | monomer | 98.55 | ||||
BFL1 in complex with a reversible covalent ligand | monomer | 100 | 1×A1H2C; | |||
Crystal Structure of Bcl-2-related protein A1 in complex with stapled peptide (AQ7)T(0EH)LRRFGD(MK8… | monomer | 98.64 | 1×CL; | |||
1 SWISS-MODEL model
Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
5uul.1.A | monomer | 0.86 | 100.00 | |||
2 SWISS-MODEL models built on isoform sequence
Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|---|
Isoform 2 | 5uul.1.A | monomer | 0.84 | 94.59 | |||
Isoform 2 | 7lk4.2.B | monomer | 0.54 | 22.96 | |||